TrialAnnals of the rheumatic diseases2011

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.

Joel M Kremer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.